Current and future recanalization strategies for acute ischemic stroke

Journal of Internal Medicine

Volumn 267, Issue 2, 2010, Pages 209-219

  Alexandrov, A V ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Outcomes; Reperfusion; Stroke; Thrombectomy; TPA; Ultrasound

Indexed keywords

ACETYLSALICYLIC ACID; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; DRUG MECHANISM; HUMAN; PRIORITY JOURNAL; THROMBECTOMY; THROMBUS ASPIRATION; TREATMENT OUTCOME;

ACUTE DISEASE; BRAIN ISCHEMIA; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; REPERFUSION; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 74849096979     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02206.x     Document Type: Conference Paper

References (62)

1. The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995 333 : 1581 1587.
2. Adams HP Jr., del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke. Stroke 2007 38 : 1655 1711.
3. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008 25 : 457 507.
4. Saqqur M, Uchino K, Demchuk AM et al. Site of arterial occlusion identified by transcranial Doppler (TCD) predicts the response to intravenous thrombolysis for stroke. Stroke 2007 38 : 948 954.
5. Marler JR, Tilley BC, Lu M et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000 55 : 1649 1655.
6. Alexandrov AV, Burgin SW, Demchuk AM, El-Mitwalli A, Grotta JC. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 2001 103 : 2897 2902.
7. Hacke W, Donnan G, Fieschi C et al. ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004 363 : 768 774.
8. Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008 359 : 1317 1329.
9. Wahlgren N, Ahmed N, Dávalos A et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008 372 : 1303 1309.
10. Davis SM, Donnan GA, Parsons MW et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008 7 : 299 309.
11. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007 38 : 967 973.
12. Saqqur M, Tsivgoulis G, Molina CA et al. Design of a PROspective multi-national collaboration on reperfusion therapies for stroke (CLOTBUST-PRO). Int J Stroke 2008 3 : 66 72.
13. Lisabeth LD, Brown DL, Morgenstern LB. Barriers to intravenous tissue plasminogen activator for acute stroke therapy in women. Gend Med 2006 3 : 270 278.
14. Labiche LA, Malkoff M, Alexandrov AV. Residual flow signals predict complete recanalization in stroke patients treated with TPA. J Neuroimaging 2003 13 : 28 33.
15. Christou I, Felberg RA, Demchuk AM et al. Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging 2002 12 : 119 123.
16. Blinc A, Francis CW, Trudnowski JL, Carstensen EL. Characterization of ultrasound-potentiated fibrinolysis in vitro. Blood 1993 81 : 2636 2643.
17. Kimura M, Iijima S, Kobayashi K, Furuhata H. Evaluation of the thrombolytic effect of tissue-type plasminogen activator with ultrasound irradiation: in vitro experiment involving assay of the fibrin degradation products from the clot. Biol Pharm Bull 1994 17 : 126 130.
18. Francis CW. Ultrasound-enhanced thrombolysis. Echocardiography 2001 18 : 239 246.
19. Alexandrov AV. Ultrasound enhanced thrombolysis for stroke. Int J Stroke 2006 1 : 26 9.
20. Alexandrov AV, Demchuk AM, Felberg RA et al. High rate of complete recanalization and dramatic clinical recovery during TPA infusion when continuously monitored by 2 MHz transcranial Doppler monitoring. Stroke 2000 31 : 610 614.
21. Demchuk AM, Burgin WS, Christou I et al. Thrombolysis in Brain Ischemia (TIBI) TCD flow grades predict clinical severity, early recovery and mortality in intravenous TPA treated patients. Stroke 2001 32 : 89 93.
22. Alexandrov AV, Wojner AW, Grotta JC. CLOTBUST: design of a randomized trial of ultrasound enhanced thrombolysis for acute ischemic stroke. J Neuroimaging 2004 14 : 108 112.
23. Alexandrov AV, Molina CA, Grotta JC et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004 351 : 2170 2178.
24. Tsivgoulis G, Molina CA, Eggers J et al. Safety and efficacy of ultrasound-enhanced thrombolysis: a meta-analysis of randomized and non-randomized studies. Stroke 2008 39 : 593 594.
25. Eggers J, Koch B, Meyer K, Konig I, Seidel G. Effect of ultrasound on thrombolysis of middle cerebral artery occlusion. Ann Neurol 2003 53 : 797 800.
26. Alexandrov AV, Grotta JC. Arterial re-occlusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002 59 : 862 867.
27. Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999 282 : 2003 2011.
28. Lewandowski CA, Frankel M, Tomsick TA et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999 30 : 2598 2605.
29. Khatri P, Hill MD, Palesch YY et al. Methodology of the interventional management of stroke III trial. Int J Stroke 2008 3 : 130 137.
30. Gobin YP, Starkman S, Duckwiler GR et al. MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004 35 : 2848 2854.
31. Smith WS, Sung G, Starkman S et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005 36 : 1432 1438.
32. Smith WS, Sung G, Saver J et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008 39 : 1205 1212.
33. Becker KJ, Brott TG. Approval of the MERCI clot retriever: a critical view. Stroke 2005 36 : 400 403.
34. Bose A, Henkes H, Alfke K et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008 29 : 1409 1413.
35. Khatri P, Neff J, Broderick JP, Khoury JC, Carrozzella J, Tomsick T IMS-I Investigators. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005 36 : 2400 2403.
36. The IMS Study II Investigators. The Interventional Management of Stroke (IMS II) Study. Stroke 2007 38 : 2127 2135.
37. Nogueira RG, Yoo AJ, Buonanno FS, Hirsch JA. Endovascular approaches to acute stroke, part 2: a comprehensive review of studies and trials. AJNR Am J Neuroradiol 2009 30 : 859 875.
38. Molina CA, Ribo M, Rubiera M et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006 37 : 425 429.
39. Perren F, Loulidi J, Poglia D, Landis T, Sztajzel R. Microbubble potentiated transcranial duplex ultrasound enhances IV thrombolysis in acute stroke. J Thromb Thrombolysis 2008 25 : 219 223.
40. Rubiera M, Ribo M, Delgado-Mederos R et al. Do bubble characteristics affect recanalization in stroke patients treated with microbubble-enhanced sonothrombolysis? Ultrasound Med Biol 2008 34 : 1573 1577.
41. Alexandrov AV, Mikulik R, Sharma VK et al. A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres (μS) for acute ischemic stroke. Stroke 2008 39 : 1464 1469.
42. Barreto AD, Sharma VK, Lao AY et al. Safety and dose-escalation study design of transcranial ultrasound in clinical sonolysis for acute ischemic stroke: the TUCSON trial. Int J Stroke 2009 4 : 42 8.
43. Molina CA, Barreto AD, Tsivgoulis G et al. Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann Neurol 2009 66 : 28 38.
44. Daffertshofer M, Gass A, Ringleb P et al. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator. Stroke 2005 36 : 1441 1446.
45. Alexandrov A, Schafer M. Operator-independent device for sonothrombolysis. Cerebrovasc Dis 2008 26 (Suppl 1 6 [abstract].
46. Burns PN. Ultrasound contrast agents in radiological diagnosis. Radiol Med 1994 87 : 71 82.
47. Alexandrov AV. Ultrasound enhancement of fibrinolysis. Stroke 2009 40 (Suppl 1 S107 10.
48. Xie F, Tsutsui JM, Lof J et al. Effectiveness of lipid microbubbles and ultrasound in declotting thrombosis. Ultrasound Med Biol 2005 31 : 979 985.
49. Culp WC, Porter TR, Lowery J, Xie F, Roberson PK, Marky L. Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine. Stroke 2004 35 : 2407 2411.
50. Sharma VK, Tsivgoulis G, Lao AY, Malkoff MD, Alexandrov AW, Alexandrov AV. Quantification of microspheres (μS) appearance in brain vessels: implications for residual flow velocity measurements, dose calculations and potential drug delivery. Stroke 2008 39 : 1476 1481.
51. http://www.strokecenter.org/trials/TrialDetail.aspx?tid=559 (accessed May 14, 2009).
52. http://www.strokecenter.org/trials/TrialDetail.aspx?tid=758 (accessed May 14, 2009).
53. Mahon BR, Nesbit GM, Barnwell SL et al. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am J Neuroradiol 2003 24 : 534 538.
54. Ramaswami R, Zhou Y, Schafer M, Zutshi R, Alexandrov AV. Ultrasound energy levels in the CLOTBUST trial: a step towards optimization of clinical sonothrombolysis. Stroke 2008 39 : 610.
55. Noser EA, Shaltoni HM, Hall CE et al. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke 2005 36 : 292 296.
56. Sugg RM, Malkoff MD, Noser EA et al. Endovascular recanalization of internal carotid artery occlusion in acute schemic stroke. AJNR Am J Neuroradiol 2005 26 : 2591 2594.
57. Ribo M, Molina CA, Alvarez B, Rubiera M, Alvarez-Sabin J, Matas M. Intra-arterial administration of microbubbles and continuous 2-MHz ultrasound insonation to enhance intra-arterial thrombolysis. J Neuroimaging 2010 20 : 1 5.
58. Kim D, Ford GA, Kidwell CS et al. Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years. AJNR Am J Neuroradiol 2007 28 : 159 163.
59. Barreto AD, Albright KC, Hallevi H et al. Thrombus burden is associated with clinical outcome after intra-arterial therapy for acute ischemic stroke. Stroke 2008 39 : 3231 3235.
60. Schellinger PD, Hacke W. Intra-arterial thrombolysis is the treatment of choice for basilar thrombosis: pro. Stroke 2006 37 : 2436 2437.
61. Smith WS. Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. Stroke 2007 38 (Suppl. 2 701 703.
62. Butcher K. Rapid advanced neuroimaging assessment in acute stroke. Int J Stroke 2009 4 : 97 100.